Compounding of GLP-1 Receptor Agonists: Current Federal and State Regulatory Landscape

Date: 08/01/24
Time: 2:00-3:30 PM ET

* Please Note: registration closes at 11:59 PM ET the day before the live event. No further registrations will be accepted once registration has been closed *

Live closed captions are available.

Overview: This webinar will discuss current issues and regulatory considerations for the compounding of GLP-1 receptor agonists including events that led to the shortage of commercially available GLP-1 receptor agonists and the impact of the shortage on compounding. The speakers will also address permissible bulk drug substances that may be used to compound GLP-1 receptor agonists, examine compounding for the medical need of individual patients, and discuss future concerns.

Learning Objectives: 

  • Understand the circumstances under which a pharmacy may compound commercially available drug products.
  • Be able to differentiate between permissible and non-permissible bulk drug substances for 503A compounding under FDA law.
  • Gain an in-depth knowledge of the current state of GLP-1 receptor agonist compounding and what we can expect in the future.

Speaker Information:

Alexander L. Snyder, Associate Attorney, Quarles & Brady LLP

Tenille Davis, Chief Advocacy Officer, Alliance for Pharmacy Compounding


Continuing Education:

CLE: IMPORTANT CHANGE REGARDING CLE CREDIT: We are now working with ABA CLE for our accreditation needs. For those who attend the LIVE webinar for at least 75 minutes, you will receive a personalized CLE affidavit from mcle-ahla@americanbar.org. Watch for this email within 7-10 business days. If you do not receive it, please check your spam or junk folders as these emails often end up there. Please note you will fill out one affidavit for the full event. Once you complete the affidavit, you will be able to download your certificate(s) of attendance and they will be emailed to you as well from mcle-ahla@americanbar.org.

CPE: AHLA is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Nashville, TN 37219-2417. Website: www.nasba.org. For further information, please visit our Continuing Education Page.

AHLA is seeking CPE credits for live and on-demand webinars. The maximum number of credits available is 1.80.